Verition Fund Management LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1454027 GREENWICH, CT

Position in PCRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$676,169

-$1,533,698 QoQ

Shares Held

29,919

-65.0% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Verition Fund Management LLC holds $14,533,555 across 10 Drug Manufacturers - Specialty & Generic names. PCRX ranks #4 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	211,287	$5,056,097
2	LNTH	Lantheus Holdings, Inc.	60,000	$4,551,000
3	LQDA	Liquidia Corp	60,111	$2,268,589
4	PCRX	Pacira BioSciences, Inc. This page	29,919	$676,169
5	VTRS	Viatris Inc	39,928	$539,427
6	TEVA	Teva Pharmaceutical Industries Ltd	13,362	$402,463
7	AMPH	Amphastar Pharmaceuticals, Inc.	18,597	$364,315
8	COLL	Collegium Pharmaceutical, Inc	10,604	$350,674

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$676,169	29,919	-65.0%	Shares	Sole	2026-05-15
2025-12-31	$2,209,867	85,389	+208.7%	Shares	Sole	2026-02-13
2025-06-30	$661,121	27,662	+43.2%	Shares	Sole	2025-08-14
2025-03-31	$480,027	19,317	-25.9%	Shares	Sole	2025-05-15
2024-12-31	$491,064	26,065	-20.5%	Shares	Sole	2025-02-14
2024-09-30	$493,459	32,788	+219.8%	Shares	Sole	2024-11-14
2023-12-31	$345,969	10,254	-10.6%	Shares	Sole	2024-02-14
2023-09-30	$352,022	11,474	+36.1%	Shares	Sole	2023-11-14
2022-12-31	$325,598	8,433	+104.8%	Shares	Sole	2023-02-14
2022-09-30	$219,036	4,118	-91.6%	Shares	Sole	2023-01-18
2022-03-31	$3,761,583	49,287	+52.4%	Shares	Other	2022-06-02
2021-12-31	$1,945,476	32,333	—	Shares	Other	2022-05-03
No filing history on record for this holder in this stock.